3.55 USD
▼-0.03-0.84%
盘后 3.51 0.00%
2026-09-16
市值
$31.09M
市盈率
—
EPS
-9.66
股息率
—
52 周区间
2.60 – 14.68
成交量
51.33K
Beta
1.53
目标价
—
52W 低 2.6052W 高 14.68
价格走势
公司简介
BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore Co...